Physician Assistant · Carthage, MO
NPI
1700245628
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2929 S Grand Ave
Carthage, MO, 64836
Phone (417) 423-1739
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$657K
7,417 prescriptions
Company payments, 2025
$698
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Asefa K Gebre prescribed most often to Medicare patients was Atorvastatin Calcium, with 407 prescriptions and refills. In total Asefa K Gebre wrote 7,417 Medicare prescriptions that cost $657K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 407 | 563 | 57 | $2,460 |
| Gabapentin Generic | 253 | 302 | 37 | $2,660 |
| Amlodipine Besylate Generic | 219 | 309 | 37 | $927 |
| Omeprazole Generic | 192 | 254 | 28 | $1,937 |
| Metformin Hcl Generic | 178 | 214 | 21 | $658 |
| Levothyroxine Sodium Generic | 156 | 194 | 22 | $885 |
| Tamsulosin Hcl Generic | 151 | 196 | 18 | $818 |
| Famotidine Generic | 144 | 156 | 21 | $1,189 |
| Losartan Potassium Generic | 134 | 195 | 18 | $664 |
| Levocetirizine Dihydrochloride Generic | 133 | 161 | 24 | $1,262 |
| Bupropion Xl Bupropion Hcl | 129 | 151 | 17 | $1,693 |
| Metoprolol Tartrate Generic | 127 | 138 | 18 | $523 |
| Montelukast Sodium Generic | 126 | 140 | 13 | $643 |
| Farxiga Dapagliflozin Propanediol | 123 | 135 | 18 | $67K |
| Potassium Chloride Generic | 120 | 127 | 20 | $946 |
Brand drugs: 1,066 claims; generic drugs: 6,278 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asefa K Gebre $698 ($698 in general payments such as food, travel and fees) from 11 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $165.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $165 |
| Abbvie Inc. ABBV | 14 | $140 |
| Lundbeck LLC | 6 | $117 |
| Globus Medical, Inc. GMED | 3 | $97.71 |
| Exact Sciences Corporation EXAS | 2 | $36.13 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $35.97 |
| Lilly USA, LLC LLY | 2 | $31.62 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $21.31 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $19.34 |
| Verona Pharma, Inc. VRNA | 1 | $19.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.